SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-145450
Filing Date
2021-12-01
Accepted
2021-12-01 16:30:59
Documents
12
Period of Report
2021-11-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134261d1_8k.htm   iXBRL 8-K 30683
  Complete submission text file 0001104659-21-145450.txt   204775

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA idra-20211126.xsd EX-101.SCH 3034
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20211126_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20211126_pre.xml EX-101.PRE 22365
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2134261d1_8k_htm.xml XML 3605
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 211463385
SIC: 2836 Biological Products, (No Diagnostic Substances)